Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)
Status:
Withdrawn
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
This is a 15 week trial to determine (1) the safety and tolerability of varenicline when used
for smoking cessation/reduction in individuals with schizophrenia; (2) if treatment with
varenicline affects the symptoms of schizophrenia.